title: Antimalarial agents: closing the gate on Toll-like receptors?
authors.forename: Robert
authors.initials: R
authors.lastname: Lafyatis
authors.forename: Michael
authors.initials: M
authors.lastname: York
authors.forename: Ann
authors.initials: A
authors.lastname: Marshak-Rothstein
mesh_terms: D000962:Antimalarials / Q000494:pharmacology* / Q000627:therapeutic use*; D018450:Disease Progression; D006801:Humans; D006886:Hydroxychloroquine / Q000097:blood; D016898:Interferon-alpha / Q000097:blood / Q000502:physiology; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D051193:Toll-Like Receptors / Q000037:antagonists & inhibitors / Q000187:drug effects* / Q000502:physiology
chemical_list: D000962:Antimalarials; D016898:Interferon-alpha; D051193:Toll-Like Receptors; D006886:Hydroxychloroquine